Comparison of cytogenetics, cytokine secretion, and oncogene expression in primary cultures of renal carcinoma cells

Oncology (Switzerland)

Volumn 54, Issue 5, 1997, Pages 429-437

  Lahn, Michael ^a   Kunzmann, R ^a   Kohler G ^b   Ikle D N ^c   Hentrich, I ^a   Jesuiter, H ^a   Kulmburg, P ^a   Veelken, E ^a   Mackensen, A ^a   Rosenthal, F ^a   Lindemann, A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Colony stimulating factor Interleukin 6; Cytokines; Granulocyte macrophage; Karyotypes; Oncogenes; Primary tumor cell culture; Renal cell carcinoma

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN P53; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER STAGING; CARCINOMA CELL; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME 7P; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; KARYOTYPE; KIDNEY CARCINOMA; MALE; ONCOGENE; ONCOGENE C FOS; ONCOGENE C MYC; ONCOGENE PAN RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNUMERARY CHROMOSOME; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, RENAL CELL; CYTOKINES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKINS; MALE; MIDDLE AGED; PROTO-ONCOGENES; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030843284     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227730     Document Type: Article

References (30)

1. Solomon E, Borrow J, Goddard AD: Chromosome aberrations and cancer. Science 1991:25: 1153-1160.
2. Rowley JD: Molecular cytogenetics: Rosetta Stone for understanding cancer - twenty-ninth G.H.A. Clowes Memorial Award Lecture. Cancer Res 1990;50:3816-3825.
3. Boman BM: Biologic functions of the genes responsible for familial cancer. Curr Opin Oncol 1994;6:90-95.
4. Zbar B, Brauch H, Talmadge C, Lindehan M: Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987;327:721-727.
5. Kovacs G, Szucs S, De Ricse W, Baumgartel FI: Specific chromosome aberration in human renal cell carcinoma. Int J Cancer 1987:40:171-178.
6. Scizinger BR, Rouleau GA, Ozclius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yeun JW. Collins D. Majoor-Krakaner D: Von Hip-pel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988;332:268-269.
7. Kovacs G, Frisch S: Clonal chromosome abnormalities in tumor cells from patients with sporadic renal carcinomas. Cancer Res 1989: 49:651-659.
8. La Forgia S, Lasota J, Latif F, Boghosian-Sell L, Kastury K, Ohta M, Druck T, Atchison L, Cannizzaro LA, Barnca G, Schlcssinger J, Modi W, Kuzmin I, Tory K, Zbar B, Croce CM, Lerman M, Huebner K: Detailed genetic and physical mapof the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation. t(3:8)(p 14.2;q24.1). Cancer Res 1993;53:3118-3124.
9. Anglard P, Trahan H, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B, Linchan WM: Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 1992;52:348-356.
10. Yoshida MA, Shimizu M, Ikeuchi T, Tonomu-ra A, Yokota J, Oshimura M: In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosomc-3 via microcell fusion. Mol Carcinog 1994;9:114-121.
11. Moch H, Presti JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 1996: 56:27-30.
12. Reiter RE, Anglard P, Liu S, Gnarra JR, Linchan WM: Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 1993:53:3092-3097.
13. Brauch H, Pomer S, Hieronymus T, Schadt T, Lohrkc H, Komitowski D: Genetic alterations in sporadic renal-cell carcinoma: Molecular analysis of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p. World J Urol 1994:12:162-168.
14. Hughson MD, Johnson LD, Silva FG, Kovacs G: Nonpapillary and papillary renal cell carcinoma: A cytogenetic and phenotypic study. Mod Pathol 1993:6:449-456.
15. Van den Berg F., Van der Hout AH, Oosterhuis JW, Storkel S, Dijkhuizen T, Dam A, Zweers HM, Mensink HJ, Buys CH, de Jong B: Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification. Int J Cancer 1993:55:223-227.
16. Kovacs G: Molecular differential pathology of renal cell tumors. Histopathology 1993:22:1- 8.
17. Beck JL, Hopman AH, Feitz WF, Schalken J, Schaafsma HE, Van de Kaa CA, Ramaekcrs FC. Hansclaar AG, De Wilde PC: Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas a detected by interphase cytogenetics. J Pathol 1995;176:123-135.
18. Tonk V, Wilson KS, Timmons CF, Schneider NR, Tomlinson GE: Renal cell carcinoma with translocation (X; 1). Further evidence for a cytogenetically defined subtype. Cancer Genet Cytogenet 1995:81:72-75.
19. Hogemann I, Bock S, Heppner P, Petrides PE: Cytogenetic and growth factor gene analysis of a renal cell carcinoma cell line. Cancer Genet Cytogenet 1994;78:175-180.
20. Ibelgaufts H: Dictionary of Cytokines. Basel. Editions Roche, 1995, pp 191,588.
21. Lahn M, Köhler G, Schmoor C, Dengler W, Veelken H, Brennscheidt U, Mackensen A, Kulmburg P, Hentrich I, Jesuiler H, Rosenthal FM, Fiebig HH, Sommerkamp H, Farthmann EH, Hasse J, Mertelsmann R, Lindemann A: Processing of tumor tissues for vaccination with autologous tumor cells. Eur Surg Res 1997:29:292-302.
22. Kunzmann R, Hölzel F: Karyotypic alterations in human ovarian carcinoma cells during longterm cultivation and nude mouse passage. Cancer Genet Cytogenet 1987;28:201-212.
23. Mitelman F: An International System for Human Cytogenetic Nomenclature (1991): ISCN (1991): Guidelines for Cancer Cytogenetics: Supplement. Basel. Karger. 1991.
24. Prcsti J, Reuter V, Cordon-Cardo C, Mazum-dar M, Fair W, Jhanwar S: Allelic deletions in renal tumors: Histopathological correlations. Cancer Res 1993;53:5780-5783.
25. Emmanuel A, Szucs S, Weier HU, Kovacs G: Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosom Cancer 1992;4:75-77.
26. Vancen Berg E, Dijkhuizen T, Storkcl S, Mo-lenaar WM, de Jong B: Chromosomal abnormalities in non-neoplastic renal tissue. Cancer Genet Cytogenet 1995:85:152-154.
27. Ishikawa I, Shikura N, Ozaki M: Papillary human renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: A karyotype analysis. Am J Kidney Dis 1993;21:553-556.
28. Von Asmuth EJU, Dentener MA, Ceska M, Buurman WA: IL-6,1L-8 and TNF production by cytokine and lipopolysaccharidc-stimulated human renal cortical epithelial cells in vitro. EurCytokine Netw 1994:5:301-310.
29. Bauer J, Herrmann F: Interleukin-6 in clinical medicine. Ann Hematol 1991;62:203-210.
30. Sozzi G, Veronese ML, Negrini M, Bafia R, Cotticelli MG, Inouc H, Tomielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M. Huebner K, Croce CM: The FHIT gene at 3pl4.2 is abnormal in lung cancer. Cell 1996; 85:17-26.